Lymphomatoid papulosis and fingolimod

Abstract

Get full access to this article

View all access options for this article.

References

Samaraweera

Cohen

Akay

. Lymphomatoid papulosis: A cutaneous lymphoproliferative disorder in a patient on fingolimod for multiple sclerosis. Mult Scler 2016; 22: 122–124.

Bolognia

Jorizzo

Schaffer

. Dermatology. 3rd ed. Philadelphia, PA: Elsevier Saunders, 2012.

Montalban

Comi

Antel

. Long-term results from a phase 2 extension study of fingolimod at high and approved dose in relapsing multiple sclerosis. J Neurol 2015; 262: 2627–2634.

Lorvik

Bogen

Corthay

. Fingolimod blocks immunosurveillance of myeloma and B-cell lymphoma resulting in cancer development in mice. Blood 2012; 119(9): 2176–2177.

Kira

Itoyama

Kikuchi

. Fingolimod (FTY720) therapy in Japanese patients with relapsing multiple sclerosis over 12 months: Results of a phase 2 observational extension. BMC Neurol 2014; 14: 21.

Gilenya (fingolimod; prescribing information). East Hanover, NJ: Novartis, 2015.

Lymphomatoid papulosis and fingolimod—A new connection?

Abstract

Get full access to this article

References